+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Sequencing Reagents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology, Application, Reagent Type, and End User

  • ID: 5359838
  • Report
  • June 2021
  • Region: Europe
  • 165 pages
  • The Insight Partners
UP TO OFF
until Sep 30th 2021

FEATURED COMPANIES

  • BGI
  • F. HOFFMANN-LA ROCHE LTD.
  • FLUIDIGM CORPORATION
  • Illumina, Inc.
  • QIAGEN
  • Takara Bio Inc.
The next generation sequencing segment by technology is estimated to lead the market growth during the forecast period.



According to this study, the Europe sequencing reagents market is expected to reach US$ 4,021.33 million by 2028 from US$ 1,819.68 million in 2021; it is estimated to grow at a CAGR of 12.0% from 2021 to 2028. The report highlights trends prevailing in the Europe sequencing reagents market and the factors driving market along with those that act as hindrances.

The Europe sequencing reagents market, by technology, is segmented into next generation sequencing, sanger sequencing, and third generation sequencing. The next generation sequencing segment held the largest share of the market in 2020. However, the sanger sequencing segment is anticipated to register the highest CAGR in the market during the forecast period. Sequencing reagents are used during the process of sequencing. The use of these reagents highly depends on the desired result to be obtained. They form an essential part of the sequencing reactions, which can be used across various other applications as well. The cost of genome sequencing has been dropping radically, nearly a million-fold in the past six-seven years. In the recent years, next generation sequencing price have declined substantially. Many of the testing services cost a couple hundred dollars and the lowered cost and higher speed could not only give them a larger margin in profits but the ability to process faster and possibly bring in a higher load of consumers. The rapid reduction in costs has now helped in clinical research, but even greater speed and a lowered price point will likely be enticing to health start-ups for the help of consumers. Hence, major market players such as Illumina and Roche have introduced breakthrough technologies that have enabled the cost and time reduction in the sequencing. Owing to factors such as advances in the field of genomics, development in different methods and strategies for sequencing, there is a notable decline in the cost of sequencing. Additionally, according to the International Diabetes Federation (IDF), the diabetes prevalence among the population is likely to increase by about 35% during the forecast period across globe. As incidence of chronic diseases are increasing at a faster pace, the research on genomics for life-threatening illnesses has progressed rapidly over the last five years, which is driving the market growth.

The rapid growth of COVID-19 confirmed cases in Europe has had a major impact on the European economy. Genome sequencing has increasingly become an important tool for studying disease outbreaks. Many countries have started reporting genomic sequences of the coronavirus from patient samples. The demand for the sequencing kits has been high since the COVID-19 pandemic emerged, thus many companies are increasing their production of reagent kits. In recent days, laboratories in Europe have ramped up genomic sequencing capabilities. The countries in the region are preferring in-house analysis than outsourcing the job. Many private and government organizations are raising funds for sequencing-based studies. Hence, COVID-19 outbreak is propelling the growth of the Europe sequencing reagents market.

The growth of the market is attributed to a few key driving factors such as the declining cost of sequencing procedures and the increasing prevalence of chronic diseases. However, the dearth of skilled professionals hinders the market growth.

QIAGEN, Takara Bio Inc., THERMO FISHER SCIENTIFIC INC., TriLink BioTechnologies Inc, BGI, F. HOFFMANN-LA ROCHE LTD., Illumina, Inc., FLUIDIGM CORPORATION and LGC Biosearch Technologies are among the leading companies operating in the Europe sequencing reagents market.

The report segments in Europe Sequencing Reagents Market as follows:

By Type
  • Automated Medication Dispensing Systems
  • Automated Packaging & Labeling Systems
  • Automated Storage & Retrieval Systems
  • Automated Compounding Devices
  • Tabletop Tablet Counters
By End User
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others
By Country
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BGI
  • F. HOFFMANN-LA ROCHE LTD.
  • FLUIDIGM CORPORATION
  • Illumina, Inc.
  • QIAGEN
  • Takara Bio Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Publisher's Research Report Guidance
1.3 Market Segmentation
1.4 Market Segmentation
1.4.1 Europe Sequencing Reagents Market - By Technology
1.4.2 Europe Sequencing Reagents Market - By Reagent Type
1.4.3 Europe Sequencing Reagents Market - By Application
1.4.4 Europe Sequencing Reagents market - By End User
1.4.5 Europe Sequencing Reagents market - By Country

2. Sequencing Reagents Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Sequencing Reagents Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe - PEST Analysis
4.3 Expert Opinions

5. Sequencing Reagents Market- Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Funding for Genomics
5.1.2 Declining Cost of Sequencing Procedures
5.1.3 Increasing Prevalence of Chronic Diseases
5.2 Market Restraints
5.2.1 Dearth of Skilled Professionals
5.3 Market Opportunities
5.3.1 Increasing Demand for Third Generation Sequencing
5.4 Future Trends
5.4.1 Increasing Demand for Personalized Medicines
5.5 Impact analysis

6. Sequencing Reagents Market - Europe Analysis
6.1 Europe Sequencing Reagents Market Revenue Forecast and Analysis

7. Sequencing Reagents Market Analysis - By Technology
7.1 Overview
7.2 Sequencing Reagents Market Revenue Share, by Technology (2020 and 2028)
7.3 Next Generation Sequencing
7.3.1 Overview
7.3.2 Next Generation Sequencing: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Sanger Sequencing
7.4.1 Overview
7.4.2 Sanger Sequencing: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Third Generation Sequencing
7.5.1 Overview
7.5.2 Third Generation Sequencing: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)

8. Sequencing Reagents Market Analysis - By Reagent Type
8.1 Overview
8.2 Sequencing Reagents Market Revenue Share, by Reagent Type (2020 and 2028)
8.3 Control Kits
8.3.1 Overview
8.3.2 Control Kits: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Library Kits
8.4.1 Overview
8.4.2 Library Kits: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Template Kits
8.5.1 Overview
8.5.2 Template Kits: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Sequencing Kits
8.6.1 Overview
8.6.2 Sequencing Kits: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Other Reagent Types
8.7.1 Overview
8.7.2 Other Reagent Types: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)

9. Sequencing Reagents Market Analysis - By Application
9.1 Overview
9.2 Sequencing Reagents Market Revenue Share, by Application (2020 and 2028)
9.3 Agrigenomics and Forensics
9.3.1 Overview
9.3.2 Agrigenomics And Forensics: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Clinical Investigation
9.4.1 Overview
9.4.2 Clinical Investigation: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Oncology
9.5.1 Overview
9.5.2 Oncology: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Reproductive Health
9.6.1 Overview
9.6.2 Reproductive Health: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
9.7 Other Applications
9.7.1 Overview
9.7.2 Other Applications: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)

10. Sequencing Reagents Market Analysis - By End User
10.1 Overview
10.2 Sequencing Reagents Market Share, by End User, 2020 and 2028, (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Research Institutes
10.4.1 Overview
10.4.2 Research Institutes: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Pharmaceutical and Biotechnology Companies
10.5.1 Overview
10.5.2 Pharmaceutical and Biotechnology Companies: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
10.6 Other End Users
10.6.1 Overview
10.6.2 Other End Users: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)

11. Sequencing Reagents Market - Europe Analysis
11.1 Europe: Sequencing Reagents Market
11.1.1 Overview
11.1.3 Europe: Sequencing Reagents Market, by Country, 2020 & 2028(%)
11.1.4 Germany: Sequencing Reagents Market - Revenue and Forecast to 2028 (USD Million)
11.1.4.1 Germany: Sequencing Reagents Market - Revenue and Forecast to 2028 (USD Million)
11.1.4.2 Germany: Sequencing Reagents Market, by Technology, 2019-2028 (USD Million)
11.1.4.3 Germany: Sequencing Reagents Market, by Reagent Type, 2019-2028 (USD Million)
11.1.4.4 Germany: Sequencing Reagents Market, by Application, 2019-2028 (USD Million)
11.1.4.5 Germany: Sequencing Reagents Market, End User, 2019-2028 (USD Million)
11.1.5 France: Sequencing Reagents Market - Revenue and Forecast to 2028 (USD Million)
11.1.5.1 France: Sequencing Reagents Market - Revenue and Forecast to 2028 (USD Million)
11.1.5.2 France: Sequencing Reagents Market, by Technology, 2019-2028 (USD Million)
11.1.5.3 France: Sequencing Reagents Market, by Reagent Type, 2019-2028 (USD Million)
11.1.5.4 France: Sequencing Reagents Market, by Application, 2019-2028 (USD Million)
11.1.5.5 France: Sequencing Reagents Market, End User- 2019-2028 (USD Million)
11.1.6 UK: Sequencing Reagents Market - Revenue and Forecast to 2028 (USD Million)
11.1.6.1 UK: Sequencing Reagents Market - Revenue and Forecast to 2028 (USD Million)
11.1.6.2 UK: Sequencing Reagents Market, by Technology, 2019-2028 (USD Million)
11.1.6.3 UK: Sequencing Reagents Market, by Reagent Type, 2019-2028 (USD Million)
11.1.6.4 UK: Sequencing Reagents Market, by Application, 2019-2028 (USD Million)
11.1.6.5 UK: Sequencing Reagents Market, End User, 2019-2028 (USD Million)
11.1.7 Italy: Sequencing Reagents Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.1 Italy: Sequencing Reagents Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.2 Italy: Sequencing Reagents Market, by Technology, 2019-2028 (USD Million)
11.1.7.3 Italy: Sequencing Reagents Market, by Reagent Type, 2019-2028 (USD Million)
11.1.7.4 Italy: Sequencing Reagents Market, by Application, 2019-2028 (USD Million)
11.1.7.5 Italy: Sequencing Reagents Market, End User, 2019-2028 (USD Million)
11.1.8 Spain: Sequencing Reagents Market - Revenue and Forecast to 2028 (USD Million)
11.1.8.1 Spain: Sequencing Reagents Market - Revenue and Forecast to 2028 (USD Million)
11.1.8.2 Spain: Sequencing Reagents Market, by Technology, 2019-2028 (USD Million)
11.1.8.3 Spain: Sequencing Reagents Market, by Reagent Type, 2019-2028 (USD Million)
11.1.8.4 Spain: Sequencing Reagents Market, by Application, 2019-2028 (USD Million)
11.1.8.5 Spain: Sequencing Reagents Market, End User, 2019-2028 (USD Million)
11.1.9 Rest of Europe: Sequencing Reagents Market - Revenue and Forecast to 2028 (USD Million)
11.1.9.1 Rest of Europe: Sequencing Reagents Market - Revenue and Forecast to 2028 (USD Million)
11.1.9.2 Rest of Europe: Sequencing Reagents Market, by Technology, 2019-2028 (USD Million)
11.1.9.3 Rest of Europe: Sequencing Reagents Market, by Reagent Type, 2019-2028 (USD Million)
11.1.9.4 Rest of Europe: Sequencing Reagents Market, by Application, 2019-2028 (USD Million)
11.1.9.5 Rest of Europe: Sequencing Reagents Market, by End User, 2019-2028 (USD Million)

12. Impact of COVID-19 Pandemic on Europe Sequencing Reagents Market
12.1 Europe: Impact Assessment of COVID-19 Pandemic

13. Sequencing Reagents Market - Industry Landscape
13.1 Overview
13.2 Organic Growth Strategies
13.2.1 Overview
13.3 Inorganic Growth Strategies
13.3.1 Overview

14. Company Profiles
14.1 QIAGEN
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Takara Bio Inc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 THERMO FISHER SCIENTIFIC INC.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 TriLink BioTechnologies Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 BGI
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 F. HOFFMANN-LA ROCHE LTD.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Illumina, Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 FLUIDIGM CORPORATION
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 LGC Biosearch Technologies
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms

List of Tables
Table 1. Germany: Sequencing Reagents Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 2. Germany: Sequencing Reagents Market, by Reagent Type - Revenue and Forecast to 2028 (USD Million)
Table 3. Germany: Sequencing Reagents Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 4. Germany: Sequencing Reagents Market, End User - Revenue and Forecast to 2028 (USD Million)
Table 5. France: Sequencing Reagents Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 6. France: Sequencing Reagents Market, by Reagent Type - Revenue and Forecast to 2028 (USD Million)
Table 7. France: Sequencing Reagents Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 8. France: Sequencing Reagents Market, End User- Revenue and Forecast to 2028 (USD Million)
Table 9. UK: Sequencing Reagents Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 10. UK: Sequencing Reagents Market, by Reagent Type - Revenue and Forecast to 2028 (USD Million)
Table 11. UK: Sequencing Reagents Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 12. UK: Sequencing Reagents Market, End User- Revenue and Forecast to 2028 (USD Million)
Table 13. Italy: Sequencing Reagents Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 14. Italy: Sequencing Reagents Market, by Reagent Type - Revenue and Forecast to 2028 (USD Million)
Table 15. Italy: Sequencing Reagents Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 16. Italy: Sequencing Reagents Market, End User - Revenue and Forecast to 2028 (USD Million)
Table 17. Spain: Sequencing Reagents Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 18. Spain: Sequencing Reagents Market, by Reagent Type - Revenue and Forecast to 2028 (USD Million)
Table 19. Spain: Sequencing Reagents Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 20. Spain: Sequencing Reagents Market, End User - Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of Europe: Sequencing Reagents Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Europe: Sequencing Reagents Market, by Reagent Type - Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Europe: Sequencing Reagents Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Europe: Sequencing Reagents Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 25. Recent Organic Developments in the Sequencing Reagents Market
Table 26. Recent Inorganic Developments in The Sequencing Reagents Market
Table 27. Glossary of Terms, Sequencing Reagents Market

List of Figures
Figure 1. Sequencing Reagents Market Segmentation
Figure 2. Sequencing Reagents Market Segmentation, By Country
Figure 3. Sequencing Reagents Market Overview
Figure 4. Next Generation Sequencing Held Largest Share by Technology of Sequencing Reagents Market
Figure 5. Europe Sequencing Reagents Market - Leading Country Markets (US$ Million)
Figure 6. Europe PEST Analysis
Figure 7. Sequencing Reagents Market Impact Analysis of Drivers and Restraints
Figure 8. Europe Sequencing Reagents Market - Revenue Forecast and Analysis - 2020- 2028
Figure 9. Sequencing Reagents Market Revenue Share, by Technology (2020 and 2028)
Figure 10. Next Generation Sequencing: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 11. Sanger Sequencing: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Third Generation Sequencing: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Sequencing Reagents Market Revenue Share, by Reagent Type (2020 and 2028)
Figure 14. Control Kits: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Library Kits: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Template Kits: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Sequencing Kits: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Other Reagent Types: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Sequencing Reagents Market Revenue Share, by Application (2020 and 2028)
Figure 20. Agrigenomics And Forensics: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Clinical Investigation: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Oncology: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Reproductive Health: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Other Applications: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Sequencing Reagents Market Share, by End User, 2020 and 2028 (%)
Figure 26. Hospitals and Clinics: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Research Institutes: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Pharmaceutical and Biotechnology Companies: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Other End Users: Sequencing Reagents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Europe: Sequencing Reagents Market, by Key Country - Revenue (2020) (USD Million)
Figure 31. Europe: Sequencing Reagents Market, by Country, 2020 & 2028 (%)
Figure 32. Germany: Sequencing Reagents Market - Revenue and Forecast to 2028 (USD Million)
Figure 33. France: Sequencing Reagents Market - Revenue and Forecast to 2028 (USD Million)
Figure 34. UK: Sequencing Reagents Market - Revenue and Forecast to 2028 (USD Million)
Figure 35. Italy: Sequencing Reagents Market - Revenue and Forecast to 2028 (USD Million)
Figure 36. Spain: Sequencing Reagents Market - Revenue and Forecast to 2028 (USD Million)
Figure 37. Rest of Europe: Sequencing Reagents Market - Revenue and Forecast to 2028 (USD Million)
Figure 38. Impact of COVID-19 Pandemic on Sequencing Reagents Market in European Countries
Note: Product cover images may vary from those shown
  • QIAGEN
  • Takara Bio Inc.
  • THERMO FISHER SCIENTIFIC INC.
  • TriLink BioTechnologies Inc
  • BGI
  • F. HOFFMANN-LA ROCHE LTD.
  • Illumina, Inc.
  • FLUIDIGM CORPORATION
  • LGC Biosearch Technologies
Note: Product cover images may vary from those shown
Adroll
adroll